Clinician participation in CADTH’s pan-Canadian Oncology Drug Review: contribution and impact on cancer drug funding recommendations

M. Trudeau, P. Hoskins, T. Reiman, A. Chambers, H. Mai, P. Wheatley-Price

Abstract


-

Keywords


Oncology; Health Technology Assessment; pan-Canadian Oncology Drug Review

Full Text:

PDF HTML


DOI: http://dx.doi.org/10.3747/co.24.3644

Bookmark and Share





Copyright © 2017 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)